(Q86120631)

English

Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients

scientific article published on 11 February 2013

Statements

Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit